Large Cap
Biological Products, Except Diagnostic Substances
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price | Price change % | |
|---|---|---|---|---|---|
 1 Amgen AMGN $172B | $172B | $321.01 | -0.43% | ||
 2 Gilead Sciences GILD $105B | $105B | $84.67 | -1.71% | ||
 3 Biogen BIIB $27.5B | $27.5B | $188.59 | +1.52% | ||
 4 Moderna MRNA $21.8B | $21.8B | $56.83 | -3.45% | ||
 5 Vaxcyte PCVX $13.8B | $13.8B | $111.60 | -0.24% | ||
 6 Bio-Techne TECH $11.6B | $11.6B | $72.98 | -1.72% | ||
 7 Neurocrine Biosciences NBIX $11.4B | $11.4B | $112.41 | +0.71% |